These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21357405)

  • 1. What reduction in standard automated perimetry variability would improve the detection of visual field progression?
    Turpin A; McKendrick AM
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3237-45. PubMed ID: 21357405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
    Artes PH; Hutchison DM; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2451-7. PubMed ID: 15980235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual field progression with frequency-doubling matrix perimetry and standard automated perimetry in patients with glaucoma and in healthy controls.
    Redmond T; O'Leary N; Hutchison DM; Nicolela MT; Artes PH; Chauhan BC
    JAMA Ophthalmol; 2013 Dec; 131(12):1565-72. PubMed ID: 24177807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeatability of automated perimetry: a comparison between standard automated perimetry with stimulus size III and V, matrix, and motion perimetry.
    Wall M; Woodward KR; Doyle CK; Artes PH
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):974-9. PubMed ID: 18952921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test-retest variability for standard automated perimetry and short-wavelength automated perimetry in diabetic patients.
    Bengtsson B; Hellgren KJ; Agardh E
    Acta Ophthalmol; 2008 Mar; 86(2):170-6. PubMed ID: 17935606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study.
    Haymes SA; Hutchison DM; McCormick TA; Varma DK; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):547-54. PubMed ID: 15671281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency doubling technology perimetry for detection of visual field progression in glaucoma: a pointwise linear regression analysis.
    Liu S; Yu M; Weinreb RN; Lai G; Lam DS; Leung CK
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2862-9. PubMed ID: 24595388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of current technology used in evaluating visual function in glaucoma.
    Turalba AV; Grosskreutz C
    Semin Ophthalmol; 2010; 25(5-6):309-16. PubMed ID: 21091017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of standard automated perimetry, frequency-doubling technology perimetry, and short-wavelength automated perimetry for detection of glaucoma.
    Liu S; Lam S; Weinreb RN; Ye C; Cheung CY; Lai G; Lam DS; Leung CK
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7325-31. PubMed ID: 21810975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
    Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency-doubling perimetry: comparison with standard automated perimetry to detect glaucoma.
    Leeprechanon N; Giangiacomo A; Fontana H; Hoffman D; Caprioli J
    Am J Ophthalmol; 2007 Feb; 143(2):263-271. PubMed ID: 17178091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency doubling technology for earlier detection of functional damage in standard automated perimetry-normal hemifield in glaucoma with low-to-normal pressure.
    Nakagawa S; Murata H; Saito H; Nakahara H; Mataki N; Tomidokoro A; Iwase A; Araie M
    J Glaucoma; 2012 Jan; 21(1):22-6. PubMed ID: 21543995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of perimetric threshold estimates from Full Threshold, SITA Standard, and SITA Fast strategies.
    Artes PH; Iwase A; Ohno Y; Kitazawa Y; Chauhan BC
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2654-9. PubMed ID: 12147599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of progressive change in automated visual fields in glaucoma.
    Smith SD; Katz J; Quigley HA
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1419-28. PubMed ID: 8641844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in patients with glaucomatous visual field damage is reduced using size V stimuli.
    Wall M; Kutzko KE; Chauhan BC
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):426-35. PubMed ID: 9040476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability components of standard automated perimetry and frequency-doubling technology perimetry.
    Spry PG; Johnson CA; McKendrick AM; Turpin A
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1404-10. PubMed ID: 11328758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial and temporal processing of threshold data for detection of progressive glaucomatous visual field loss.
    Spry PG; Johnson CA; Bates AB; Turpin A; Chauhan BC
    Arch Ophthalmol; 2002 Feb; 120(2):173-80. PubMed ID: 11831919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic sensitivity of fast blue-yellow and standard automated perimetry in early glaucoma: a comparison between different test programs.
    Bengtsson B; Heijl A
    Ophthalmology; 2006 Jul; 113(7):1092-7. PubMed ID: 16815399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual field progression in glaucoma: total versus pattern deviation analyses.
    Artes PH; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SITA standard in optic neuropathies and hemianopias: a comparison with full threshold testing.
    Wall M; Punke SG; Stickney TL; Brito CF; Withrow KR; Kardon RH
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):528-37. PubMed ID: 11157893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.